<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "niMODipine tab>
<dose><value>60</value>
<value>90</value>
<value>30</value>
</dose><route><value>PO</value>
</route><form><value>tab</value>
</form><drug><value>niMODipine tab</value>
</drug><strength><value>30 mg</value>
</strength><frequency><value>Q4H</value>
</frequency><instruction><value>for 21 consecutive days after diagnosis of SAH.</value>
</instruction><volume><value></value>
</volume><units><value>mg</value>
</units><additionalnotes><value></value>
<value>Consideration in patients with hepatic insufficency due to substantially reduced clearance and approximately doubled maximum plasma concentrations.</value>
</additionalnotes><population><value></value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value></value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>Calcium-Channel Blocking Agents, Dihydropyridines</value>
</ahfsname><highalert><value></value>
</highalert><maximumprndose><value></value>
</maximumprndose></drug>